-
EP3765476
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3765476
| EP3765476 - MODIFIED OLIGONUCLEOTIDES FOR USE IN TREATMENT OF TAUOPATHIES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 18.12.2020 Database last updated on 19.10.2024 | |
| Former | The international publication has been made Status updated on 21.09.2019 | ||
| Former | unknown Status updated on 03.04.2019 | Most recent event Tooltip | 16.02.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [2021/03] | Inventor(s) | 01 /
EBNETH, Andreas Turnhoutseweg 30 2340 Beerse / BE | 02 /
VAN OUTRYVE D'YDEWALLE, Constantin Turnhoutseweg 30 2340 Beerse / BE | 03 /
GRYAZNOV, Sergei 260E.Grand Ave.,2nd Floor South San Francisco, CA 94080 / US | 04 /
MARTINEZ MONTERO, Saúl 260 E.Grand Ave., 2nd Floor, South San Francisco, CA 94080 / US | 05 /
RAJWANSHI, Vivek Kumar 260 E Grand Ave, 2nd Floor South San Francisco, CA 94080 / US | 06 /
BEIGELMAN, Leonid 260 E Grand Ave, 2nd Floor South San Francisco, CA 94080 / US | [2021/03] | Representative(s) | Snaith, James Michael Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
| Former [2021/03] | Quaghebeur, Luc Johnson & Johnson Patent Law Department Turnhoutseweg 30 2340 Beerse / BE | Application number, filing date | 19712535.4 | 13.03.2019 | [2021/03] | WO2019EP56312 | Priority number, date | US201862642499P | 13.03.2018 Original published format: US 201862642499 P | [2021/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2019175260 | Date: | 19.09.2019 | Language: | EN | [2019/38] | Type: | A2 Application without search report | No.: | EP3765476 | Date: | 20.01.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.09.2019 takes the place of the publication of the European patent application. | [2021/03] | Search report(s) | International search report - published on: | EP | 14.11.2019 | Classification | IPC: | C07H21/00, C12N15/113, A61K31/7088, A61P25/28 | [2021/03] | CPC: |
C07H21/00 (EP,IL,KR);
C12N15/113 (EP,IL,KR,US);
A61K31/7125 (EP,IL,KR);
A61P25/28 (EP,IL,KR,US);
C12N2310/11 (EP,IL,KR,US);
C12N2310/315 (EP,IL,KR,US);
C12N2310/321 (EP,IL,KR,US);
C12N2310/322 (EP,IL,KR);
C12N2310/3341 (US);
C12N2310/335 (EP,IL,KR);
C12N2310/341 (EP,IL,KR);
C12N2310/345 (EP,IL,KR);
C12N2310/346 (US);
C12N2310/3521 (IL);
C12N2310/3525 (IL);
C12N2320/50 (US)
(-)
| C-Set: |
C12N2310/321, C12N2310/3521 (EP);
C12N2310/322, C12N2310/3525 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/03] | Extension states | BA | 13.10.2020 | ME | 13.10.2020 | Validation states | KH | 13.10.2020 | MA | 13.10.2020 | MD | 13.10.2020 | TN | 13.10.2020 | Title | German: | MODIFIZIERTE OLIGONUKLEOTIDE ZUR VERWENDUNG BEI DER BEHANDLUNG VON TAUOPATHIEN | [2021/03] | English: | MODIFIED OLIGONUCLEOTIDES FOR USE IN TREATMENT OF TAUOPATHIES | [2021/03] | French: | OLIGONUCLÉOTIDES MODIFIÉS ET MÉTHODES D'UTILISATION DANS LES TAUOPATHIES | [2021/03] | Entry into regional phase | 13.10.2020 | National basic fee paid | 13.10.2020 | Designation fee(s) paid | 13.10.2020 | Examination fee paid | Examination procedure | 13.10.2020 | Examination requested [2021/03] | 13.10.2020 | Date on which the examining division has become responsible | 29.04.2021 | Amendment by applicant (claims and/or description) | Divisional application(s) | EP21170299.8 / EP3922637 | Fees paid | Renewal fee | 12.03.2021 | Renewal fee patent year 03 | 17.02.2022 | Renewal fee patent year 04 | 14.02.2023 | Renewal fee patent year 05 | 15.02.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YD]WO0118015 (GERON CORP [US], et al) [YD] 1-38,41,46-48,56,61-63,89-102 * abstract * * page 3, line 16 - page 5, line 14 *; | [Y]WO2007107789 (SYLENTIS SA [ES], et al) [Y] 1-38,41,46-48,56,61-63,89-102 * abstract * * page 11, line 5 - page 14, line 25 *; | [Y]US2014121261 (GRYAZNOV SERGEI M [US], et al) [Y] 1-38,41,46-48,56,61-63,89-102 * abstract * * [0106]-[0108] *; | [Y]WO2014153236 (ISIS PHARMACEUTICALS INC [US]) [Y] 39-64 * abstract * * pages 73-76; table 9 *; | [X]WO2015010135 (ISIS PHARMACEUTICALS INC [US]) [X] 39,40,42-45,49-55,57-60,64 * the whole document * * tables 9-66 * * pages 22-26; compounds Ia, IIa, IIIa, IVa, Va * * page 35, lines 5-20 *; | [XY]WO2016126995 (BRISTOL MYERS SQUIBB CO [US], et al) [X] 39,40,42-45,49-55,57-60,64 * abstract * * [0166], [0246]-[0251], [0314]-[0347] * * figures 2, 3, 6, 7, 16 and 20 * [Y] 1-38,41,46-48,56,61-63,89-102; | [XY]WO2017109679 (NOVARTIS AG [CH]) [X] 39,40,42-45,49-55,57-60,64 * abstract * * [0005]-[0011], [0027], [0030]-[0031], [0036], [0065]-[0078], [0083] * [Y] 1-38,41,46-48,56,61-63,89-102; | [Y] - KRISZTINA PONGRACZ ET AL, "Novel Short Oligonucleotide Conjugates as Inhibitors of Human Telomerase", NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS., US, (20031001), vol. 22, no. 5-8, doi:10.1081/NCN-120023085, ISSN 1525-7770, pages 1627 - 1629, XP055434021 [Y] 1-38,41,46-48,56,61-63,89-102 * the whole document * DOI: http://dx.doi.org/10.1081/NCN-120023085 | [Y] - LOUIS P. CONWAY ET AL, "The synthesis, conformation and hydrolytic stability of an N,S-bridging thiophosphoramidate analogue of thymidylyl-3',5'-thymidine", ORGANIC & BIOMOLECULAR CHEMISTRY, (20160101), vol. 14, no. 30, doi:10.1039/C6OB01270A, ISSN 1477-0520, pages 7361 - 7367, XP055606690 [Y] 1-38,41,46-48,56,61-63,89-102 * the whole document * * compound 1 * DOI: http://dx.doi.org/10.1039/C6OB01270A | [Y] - R. SCHULTZ ET AL, "Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties", NUCLEIC ACIDS RESEARCH, (19960801), vol. 24, no. 15, doi:10.1093/nar/24.15.2966, pages 2966 - 2973, XP055626548 [Y] 39-64 * the whole document * DOI: http://dx.doi.org/10.1093/nar/24.15.2966 | by applicant | WO0118015 | US6268490 | US6525191 | US6770748 | US6794499 | US7034133 | US7053207 | US7084125 | US7217805 | US7314923 | US7569575 | US7696345 | - DEVOS et al., Sci Transl Med., (20170125), vol. 9, no. 374 | - HANGER et al., Trends Mol Med., (20090000), vol. 15, pages 112 - 9 | - WISCHIK et al., Proc Natl Acad Sci USA, (19880000), vol. 85, pages 4884 - 8 | - MORRIS et al., Neuron, (20110000), vol. 70, pages 410 - 26 | - Nucleic Acids Research, (19950000), vol. 23, no. 14, pages 2661 - 2668 | - Nucleic Acids Research, (19960000), vol. 24, no. 15, pages 2966 - 2973 |